Tests whole fruit effects on blood sugar in type 2 diabetes
Tests eating whole fruit in adults with type 2 diabetes not using insulin.
Key facts
- Who runs it
- Harvard School of Public Health (HSPH)
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Effects of Whole Fruit on Blood Sugar in People With Type 2 Diabetes
- Status
- Not yet recruiting
- People taking part
- 25 people, planned
- Started
- Sept 2026
- Expected to end
- Apr 2028
- Type of study
- Interventional
- Treatments tested
- Whole Fruit
- Record updated
- 7 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 2 diabetes who do not take insulin, to study the effects of eating whole fruit on blood sugar, liver fat and heart health.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Type 2 diabetes with HbA1c between 6.5-12.0% (48–108 mmol/mol) and fasting C-peptide level of at least 0.5 ng/ml (no beta-cell failure).
- Earlier treatment
- Cannot be on insulin or weight loss medication, including GLP-1 receptor agonists (e.g., semaglutide, dulaglutide). No change in dose of a long-term medication that may affect the results in the past 3 months.
- Biomarker or test result
- HbA1c between 6.5-12.0% (48–108 mmol/mol); fasting C-peptide level of at least 0.5 ng/ml.
Main reasons for not taking part
- On insulin
- Latent autoimmune diabetes (LADA) or maturity-onset diabetes of the young (MODY)
- eGFR below 45 ml/min per 1.73 m²
- Heart attack in the past 6 months or severe/unstable heart failure
- Pregnant, planning pregnancy in the next 6 months, or breastfeeding
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Aged ≥18 years
- Diagnosed with type 2 diabetes
- HbA1c between 6.5-12.0%
- Fasting C-peptide level ≥0.5 ng/ml, indicating the patient does not have beta-cell failure, as measured at screening
Who cannot take part
- On weight loss medication, including GLP-1 receptor agonists (e.g., semaglutide, dulaglutide)
- Change in the dosage of a chronic medication that may affect study endpoints within the past 3 months
- Evidence of latent autoimmune diabetes (LADA) or maturity-onset diabetes of the young (MODY)
- Heart attack in the past 6 months or severe/unstable heart failure
- Significant gastrointestinal disease, major gastrointestinal surgery, or gallstones
- Significant cardiovascular, renal, cardiac, liver, lung, adrenal, or nervous system disease that might compromise participant safety or data validity
- Evidence of cancer (other than non-melanoma skin cancer) within the last 5 years
- Major psychiatric condition that would affect the ability to participate in the study
- Not able to eat the provided study meals (e.g., food allergies)
- Estimated glomerular filtration rate (eGFR) <45 ml/min per 1.73 m²
- Clinically significant laboratory abnormality (e.g., abnormal hemoglobin levels)
- On insulin
- Lost or gained more than 5 lbs (or more than 2% of body weight if the patient weighs >250 lbs) of weight in the past 2 months
- Pregnant, planning to become pregnant in the next 6 months, or breastfeeding
- Behavioral factors or circumstances that may impede adherence to the dietary intervention
- Not able to undergo the MRI scan (e.g., due to claustrophobia, implanted metal objects, or body girth ≥60 cm)
Where in United States
- Harvard T.H. Chan School of Public HealthBoston, United StatesContact: Kathleen JohnsonNot yet recruiting
About the trial
What the trial wants to find out
This study will determine the effects of consuming whole fruit on blood sugar control, liver fat, and cardiovascular health in adults with type 2 diabetes who are not treated with insulin.
The group in the trial
- Whole FruitTreatment being tested
Participants will consume a large amount of whole fruit, constituting 50% of total calories.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effects of Whole Fruit on Glycemic Control, Liver Fat, and Cardiovascular Disease Risk Factors in Adults With Type 2 Diabetes
- Plain-language title
- Tests whole fruit effects on blood sugar in type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 7 July 2026